Trientine and Carboplatin in Advanced Malignancies

NCT01178112 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Trientine
DRUG: Carboplatin
DRUG: Trientine MTD
DRUG: Carboplatin MTD
OTHER: PK Testing

Sponsor

M.D. Anderson Cancer Center